| Net Cash Provided by (Used in) Operating Activities |
$212,007,000 |
USD |
|
Q4 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$164,033,000 |
USD |
-169% |
Q4 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
500,000,000 |
shares |
43% |
Q4 2025 |
Q1 2025 |
| Common Stock, Shares, Issued |
263,384,785 |
shares |
-0.8% |
Q4 2025 |
Q1 2025 |
| Common Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q4 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$160,542,000 |
USD |
-27% |
Q4 2025 |
Q1 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$53,140,000 |
USD |
-23% |
Q4 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$6,981,000 |
USD |
|
Q3 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q4 2025 |
Q1 2025 |
| Preferred Stock, Shares Authorized |
1,000,000 |
shares |
0% |
Q4 2025 |
Q1 2025 |
| Additional Paid in Capital |
$3,995,213,000 |
USD |
-4.6% |
Q4 2025 |
Q1 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q4 2025 |
Q1 2025 |
| Interest Expense |
$186,423,000 |
USD |
34% |
Q2 2024 |
Q3 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q4 2025 |
Q1 2025 |